Dr Gregory Williams, in Merrimack, NH - Medicare Family Medicine

Dr Gregory Williams, is a medicare enrolled "Family Medicine" physician in Merrimack, New Hampshire. His current practice location is 382 Dw Hwy, Merrimack, New Hampshire. You can reach out to his office (for appointments etc.) via phone at (603) 424-4181.

Dr Gregory Williams is licensed to practice in New Hampshire (license number 11119) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1427045632.

Contact Information

	Dr Gregory Williams,
	382 Dw Hwy, Merrimack, NH 03054-4152
	(603) 424-4181
	Not Available

Physician's Profile

Full Name	Dr Gregory Williams
Gender	Male
Speciality	Family Medicine
Location	382 Dw Hwy, Merrimack, New Hampshire
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1427045632
Provider Enumeration Date: 10/03/2005
Last Update Date: 08/23/2012

Medicare PECOS Information:

PECOS PAC ID: 8527090547
Enrollment ID: I20050909000705

Medical Identifiers

Medical identifiers for Dr Gregory Williams such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427045632	NPI	-	NPPES
110061100/A	Medicaid	MA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	11119 (New Hampshire)	Primary
207Q00000X	Family Medicine	154397 (Massachusetts)	Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Gregory Williams allows following entities to bill medicare on his behalf.

Entity Name	Lahey Clinic Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097

News Archive

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

Each day, normal human cell tissues express a protein known as p53 that wages war against potential malignancies. However, between 30 and 40 percent of human breast cancers express a defective (mutant) form of p53 that helps cancer cells proliferate and grow.

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.

Bioheart's executive management team strengthened by the inclusion of board members

Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and other cardiovascular diseases announced today that several of its Directors have joined the Company's executive management team. In addition to assuming the position of Chairman of the Company's Board of Directors, Karl E. Groth, Ph.D., became the Chief Executive Officer; Peggy A. Farley became Chief Operating Officer; and Mark P. Borman became Chief Financial Officer. Howard Leonhardt will continue as Chief Scientific and Technology Officer, and Chairman of the Scientific Advisory Board. Mr. Leonhardt, the Company's founder, thus will be able to focus on enhancing the Company's existing technologies and strengthening its position as the leader within the cardiovascular arena of the stem cell therapy industry.

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Researchers at Mayo Clinic in Florida participated in a nationwide study that found minor differences between genes that contribute to late-onset Alzheimer's disease in African-Americans and in Caucasians.

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.

Bioheart's executive management team strengthened by the inclusion of board members

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gregory Williams is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gregory Williams, Po Box 808, Nashua, NH 03061-0808 Ph: (603) 578-5054	Dr Gregory Williams, 382 Dw Hwy, Merrimack, NH 03054-4152 Ph: (603) 424-4181

News Archive

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

QIAGEN N.V. today announced the launch of the QIAsure Methylation Test, a novel CE-marked molecular diagnostic test for use in differentiating patients' risk of developing cervical cancer.

Bioheart's executive management team strengthened by the inclusion of board members

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Family Medicine Doctors in Merrimack, NH

Dr. Edward Brooks Hall, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 294 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4713 Fax: 603-424-2915
Dr. Nicola Kernan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Dobson Way, Merrimack, NH 03054 Phone: 603-424-4181
Dr. Christopher Couture, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 696 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-429-3155 Fax: 603-424-8693
Dr. William Stewart Blackwood, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 382 Daniel Webster Hwy, Merrimack, NH 03054 Phone: 603-424-4181
Dr. Anica Naprta, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 7 Executive Park Drive, Home Health & Hospice Care, Merrimack, NH 03054 Phone: 603-882-2941 Fax: 603-429-1844
Dr. Archie W Dickinson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 294 Daniel Webster Hwy, Dartmouth Hitchcock - Family Medicine, Merrimack, NH 03054 Phone: 603-424-4713

Dr Gregory Williams, - Medicare Family Medicine in Merrimack, NH

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

Bioheart's executive management team strengthened by the inclusion of board members

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

Bioheart's executive management team strengthened by the inclusion of board members

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Combination therapy effectively induces tumor cell death and reduces spread of breast cancer

QIAGEN announces launch of QIAsure Methylation Test to detect cervical cancer risk

Bioheart's executive management team strengthened by the inclusion of board members

Researchers study gene that contributes to late-onset Alzheimer's disease in African-Americans

Family Medicine Doctors in Merrimack, NH